8 results Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. Stibbe advises care chain Goed Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund CM, on the sale of its hearing centres chain to Audika Belgium. Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma. Stibbe advises Flemish government Stibbe assisted the Flemish government in developing a legal framework for granting guarantees to funds, as a result of which financial institutions can free up capital to continue lending to the market. New deal for online deals - EU consumer protection adapted to the digital era As part of the New Deal for Consumers, aimed to strengthen EU consumer protection in light of the digital era, a new Directive 2019/2161 of 27 November 2019 has been adopted. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
Stibbe advises care chain Goed Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund CM, on the sale of its hearing centres chain to Audika Belgium.
Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma.
Stibbe advises Flemish government Stibbe assisted the Flemish government in developing a legal framework for granting guarantees to funds, as a result of which financial institutions can free up capital to continue lending to the market.
New deal for online deals - EU consumer protection adapted to the digital era As part of the New Deal for Consumers, aimed to strengthen EU consumer protection in light of the digital era, a new Directive 2019/2161 of 27 November 2019 has been adopted.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.